Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia

被引：0
作者：
Abdallah, Aya M. [1 ]
Hafez, Hanafy [1 ,2 ]
Madney, Youssef [1 ,2 ]
Ahmed, Sonia [1 ,2 ]
Yassin, Dina [3 ,4 ]
Salem, Sherine [3 ,4 ]
Yousry, Rodina [5 ]
Abdel-Azim, Hisham [6 ]
Lehmann, Leslie [7 ]
Elhaddad, Alaa [1 ,2 ]
机构：
[1] Childrens Canc Hosp Egypt CCHE 57357, Dept Pediat Oncol, Cairo, Egypt
[2] Cairo Univ, Natl Canc Inst, Dept Pediat Oncol, Cairo, Egypt
[3] Childrens Canc Hosp Egypt CCHE 57357, Dept Clin Pathol, Cairo, Egypt
[4] Cairo Univ, Natl Canc Inst, Dept Clin Pathol, Cairo, Egypt
[5] Childrens Canc Hosp CCHE 57357, Dept Res, Cairo, Egypt
[6] Loma Linda Univ, Children Hosp & Med Ctr, Ctr Canc, Loma Linda, CA USA
[7] Dana Farber Canc Inst, Pediat Stem Cell Transplantat Unit, Boston, MA 02115 USA
来源：
LEUKEMIA & LYMPHOMA | 2024年 / 65卷 / 07期
关键词：
Chronic myeloid leukemia; tyrosine kinase inhibitors; children; BCR-ABL; IMATINIB; CHILDREN; IMPACT;
D O I：
10.1080/10428194.2024.2331625
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1024 / 1027
页数：4
相关论文
共 16 条
  • [1] Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study
    Cortes, Jorge E.
    Jiang, Qian
    Wang, Jianxiang
    Weng, Jianyu
    Zhu, Huanling
    Liu, Xiaoli
    Hochhaus, Andreas
    Kim, Dong-Wook
    Radich, Jerald
    Savona, Michael
    Martin-Regueira, Patricia
    Sy, Oumar
    Gurnani, Renuka
    Saglio, Giuseppe
    [J]. LEUKEMIA, 2020, 34 (08) : 2064 - 2073
  • [2] Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial
    Cortes, Jorge E.
    Saglio, Giuseppe
    Kantarjian, Hagop M.
    Baccarani, Michele
    Mayer, Jiri
    Boque, Concepcion
    Shah, Neil P.
    Chuah, Charles
    Casanova, Luis
    Bradley-Garelik, Brigid
    Manos, George
    Hochhaus, Andreas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (20) : 2333 - U54
  • [3] Chronic Myeloid Leukemia, Version 2.2021
    Deininger, Michael W.
    Shah, Neil P.
    Altman, Jessica K.
    Berman, Ellin
    Bhatia, Ravi
    Bhatnagar, Bhavana
    DeAngelo, Daniel J.
    Gotlib, Jason
    Hobbs, Gabriela
    Maness, Lori
    Mead, Monica
    Metheny, Leland
    Mohan, Sanjay
    Moore, Joseph O.
    Naqvi, Kiran
    Oehler, Vivian
    Pallera, Arnel M.
    Patnaik, Mrinal
    Pratz, Keith
    Pusic, Iskra
    Rose, Michal G.
    Smith, B. Douglas
    Snyder, David S.
    Sweet, Kendra L.
    Talpaz, Moshe
    Thompson, James
    Yang, David T.
    Gregory, Kristina M.
    Sundar, Hema
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (10): : 1385 - 1415
  • [4] Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program
    Gabert, J
    Beillard, E
    van der Velden, VHJ
    Bi, W
    Grimwade, D
    Pallisgaard, N
    Barbany, G
    Cazzaniga, G
    Cayuela, JM
    Cavé, H
    Pane, F
    Aerts, JLE
    De Micheli, D
    Thirion, X
    Pradel, V
    González, M
    Viehmann, S
    Malec, M
    Saglio, G
    van Dongen, JJM
    [J]. LEUKEMIA, 2003, 17 (12) : 2318 - 2357
  • [5] European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
    Hochhaus, A.
    Baccarani, M.
    Silver, R. T.
    Schiffer, C.
    Apperley, J. F.
    Cervantes, F.
    Clark, R. E.
    Cortes, J. E.
    Deininger, M. W.
    Guilhot, F.
    Hjorth-Hansen, H.
    Hughes, T. P.
    Janssen, J. J. W. M.
    Kantarjian, H. M.
    Kim, D. W.
    Larson, R. A.
    Lipton, J. H.
    Mahon, F. X.
    Mayer, J.
    Nicolini, F.
    Niederwieser, D.
    Pane, F.
    Radich, J. P.
    Rea, D.
    Richter, J.
    Rosti, G.
    Rousselot, P.
    Saglio, G.
    Saussele, S.
    Soverini, S.
    Steegmann, J. L.
    Turkina, A.
    Zaritskey, A.
    Hehlmann, R.
    [J]. LEUKEMIA, 2020, 34 (04) : 966 - 984
  • [6] Discontinuation of tyrosine kinase inhibitors based on BCR-ABL1 monitoring by digital droplet PCR in pediatric chronic myeloid leukemia
    Kim, Yeojae
    Kim, Seongkoo
    Lee, Jong Mi
    Ahn, Ari
    Yoo, Jae Won
    Lee, Jae Wook
    Cho, Bin
    Chung, Nack-Gyun
    Kim, Yonggoo
    Kim, Myungshin
    [J]. FRONTIERS IN PEDIATRICS, 2022, 10
  • [7] Assessment of BCR-ABL1 Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors
    Marin, David
    Ibrahim, Amr R.
    Lucas, Claire
    Gerrard, Gareth
    Wang, Lihui
    Szydlo, Richard M.
    Clark, Richard E.
    Apperley, Jane F.
    Milojkovic, Dragana
    Bua, Marco
    Pavlu, Jiri
    Paliompeis, Christos
    Reid, Alistair
    Rezvani, Katayoun
    Goldman, John M.
    Foroni, Letizia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (03) : 232 - 238
  • [8] Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study
    Millot, Frederic
    Guilhot, Joelle
    Baruchel, Andre
    Petit, Arnaud
    Bertrand, Yves
    Mazingue, Francoise
    Lutz, Patrick
    Verite, Cecile
    Berthou, Christian
    Galambrun, Claire
    Sirvent, Nicolas
    Yakouben, Karima
    Schmitt, Claudine
    Gandemer, Virginie
    Reguerre, Yves
    Couillault, Gerard
    Mechinaud, Francoise
    Cayuela, Jean-Michel
    [J]. BLOOD, 2014, 124 (15) : 2408 - 2410
  • [9] Harmonization of molecular monitoring of CML therapy in Europe
    Mueller, M. C.
    Cross, N. C. P.
    Erben, P.
    Schenk, T.
    Hanfstein, B.
    Ernst, T.
    Hehlmann, R.
    Branford, S.
    Saglio, G.
    Hochhaus, A.
    [J]. LEUKEMIA, 2009, 23 (11) : 1957 - 1963
  • [10] Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia
    Pfirrmann, M.
    Baccarani, M.
    Saussele, S.
    Guilhot, J.
    Cervantes, F.
    Ossenkoppele, G.
    Hoffmann, V. S.
    Castagnetti, F.
    Hasford, J.
    Hehlmann, R.
    Simonsson, B.
    [J]. LEUKEMIA, 2016, 30 (01) : 48 - 56
12